According to Mars Finance, Gate.com data shows that at the opening of the US stock market, the Dow Jones Industrial Average fell 0.33%, the S&P 500 fell 0.15%, and the Nasdaq Composite fell 0.13%. Novo Nordisk (NVO.N) plunged 15.65% after the company stated that its weight-loss drug Cagrisema was less effective than Eli Lilly's Zepbound in clinical trials. Eli Lilly (LLY.N) opened 3.86% higher.
At the opening of US stock markets, the Dow Jones Industrial Average fell 0.33%, while Novo Nordisk plunged 15.65%.
This article is machine translated
Show original
Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share